期刊文献+

血清趋化素与妊娠期肥胖及胰岛素抵抗的关系 被引量:3

Relationship between serum chemerin level and obesity,and insulin resistance during pregnancy
原文传递
导出
摘要 目的:探讨血清趋化素(chemerin)与妊娠期肥胖与胰岛素抵抗的关系。方法:测量其产前体重、空腹血糖(fasting plasma glucose,FPG)、空腹胰岛素(fasting insulin,FINS)等临床指标,ELISA检测血清中chemerin水平。结果:肥胖的GDM患者血清chemerin水平显著升高,表现出明显的胰岛素抵抗。血清chemerin水平与总胆固醇(total cholesterol,TC)、甘油三酯(triglyceride,TG)、C-反应蛋白(C-reactive protein,CRP)正相关。结论:chemerin通过影响血脂代谢,引起妊娠期肥胖及胰岛素抵抗。 Objective: To explore the relationship between serum chemerin level and obesity , and insulin resistance during preg- nancy. Methods: Thirty individuals with gestational diabetes mellitus (CDM) and 22 healthy control subjects were enrolled in this study. Prenatal weight, fasting plasma glucose (FPG) and fasting insulin (FINS) were measured , ehemerin levels were detected by ELISA.. Results: The serum levels of cbemerin significantly increased in obesity women with GDM, and showed obviously insulin resistance. The serum levels of chemerin were positively related with TC, TG and CRP. Conclusion: By influencing lipid metabolism, chemerin cause o- besity and insulin resistance durinz pregnancy.
出处 《中国妇幼保健》 CAS 北大核心 2013年第36期5941-5944,共4页 Maternal and Child Health Care of China
基金 国家自然科学基金项目资助〔81160082〕
关键词 肥胖 胰岛素抵抗 血清趋化素 Obesity Insulin resistance Chemerin
  • 相关文献

参考文献17

  • 1程飞,郭晓蕙,杨慧霞,卢桂芝,惠岩,陈澜.妊娠糖尿病患者血清脂联素水平及其临床意义[J].北京医学,2009,31(6):337-339. 被引量:7
  • 2杨慧霞,董悦,李苹,吴北生,徐阳.妊娠期糖尿病孕妇的脂代谢变化[J].中华围产医学杂志,1998,1(1):19-21. 被引量:29
  • 3Chen X,Scholl To, Leskiw M, et al. Differences in maternalcirculating fatty acid compostition and dietary fat intake inwomen with gestational diabetes mellitus or mild gestation hy-perglycemia [J]. Diabetes care,2010,33 ( 9): 2049-2054.
  • 4Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a no-vel adipokine associated with obesity and metabolic syndrome[J] . Endocrinology, 2007,148 (10) : 4687 - 4694.
  • 5Stejskal D, Karpisek M,Hanulova Z,et al. Chemerin is anindependent marker of the metabolic syndrome in a Caucasianpopulation - a pilot study[ J]. Biomed Pap Med Fac UnivPalacky Olomouc Czech Repub, 2008,152 (2) : 217 -221.
  • 6Sang Hui Chu, Mi Kyung Lee, Ki Yong Ahn, et aL Chemerinand adiponectin contribute reciprocally to metabolic syndrome[J] . PLoS One, 2012,7 (4) e34710.
  • 7Tonjes A, Fasshauer M, Kratzsch J, et al. Adipokine patternin subjects with impaired fasting glucose and impaired glucosetolerance in comparison to normal glucose tolerance and diabe-tes [J]. PLoS One, 2010,5: el3911.
  • 8Tan BK, Chen J, Farhatullah S, et al. Insulin and metforminregulate circulating and adipose tissue chemerin[ J]. Diabetes2009, 58; 1971 -1977.
  • 9Hanley AJ,Retnakaran R,Qi Y, et al. Association of hema-tological parameters with insulin resistence and beta - cell dys-function in nondiabetic subjects[ J],Clin Endocrinol 2009,94 (10) : 3824 -32.
  • 10Bozaoglu K, Bolton K,Me Millan J, et al. Chemerin is anovel adipokine associated with obesity and metabolic syn-11Jialal I,Devaraj S, Kaur H,et al. Increased chemerin anddecreased omentin - 1 in both adipose tissue and plasma innascent metabolic syndrome (J] . J Clin Endocrinol Metab,2013,98: E514-E517.

二级参考文献1

共引文献33

同被引文献13

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部